You'll see psoriasis patients on a new biotech drug, Raptiva.

You'll see psoriasis patients on a new biotech drug, Raptiva. It's an antibody that blocks T-cells responsible for psoriasis.

Raptiva (efalizumab) is similar to Amevive (alefacept)... but each drug blocks different cell receptors.

Raptiva is for moderate to severe plaque psoriasis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote